REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Transcenta Holding Limited (Hong Kong) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Transcenta Holding Limited Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Transcenta Holding Limited is a company located in Hong Kong. The company was incorporated on November 11, 1996. The company's history and its main products and services are not mentioned in the source. The customers and main markets of the company are also not mentioned.

Headquarters
B6-501, 218 Xinghu Street, Biobay
Suzhou; Jiangsu; Postal Code: 215123

Contact Details: Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.

Website: http://www.transcenta.com

Basic Information
Total Employees:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Registered Capital:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Transcenta Holding Limited (Hong Kong) report to view the information.
Incorporation Date:
August 20, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
13.76%
Purchase this report to view the information.
9.27%
Purchase this report to view the information.
7.92%
Purchase this report to view the information.
6.12%
Purchase this report to view the information.
5.26%
Subsidiaries
Mabspace Biosciences Co., Limited (Hong Kong SAR, China)
100%
Transcenta Biotherapeutics Inc. (United Kingdom)
100%
Transcenta Therapeutics Inc. (United States)
100%
Company Performance
Financial values in the chart are available after Transcenta Holding Limited (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
65.84%▲
Total operating revenue
107.75%▲
Operating profit (EBIT)
-28.34%▼
EBITDA
-32.82%▼
Net Profit (Loss) for the Period
-16.45%▼
Total assets
-20.48%▼
Total equity
-29.75%▼
Operating Profit Margin (ROS)
199.63%▲
Net Profit Margin
279.33%▲
Return on Equity (ROE)
-7.61%▼
Debt to Equity Ratio
11.95%▲
Quick Ratio
-1.07%▼
Cash Ratio
-0.89%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Hubei Biocause Pharmaceutical Co.,Ltd.
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Jacobio Pharmaceuticals Group Company Limited
 
Chengdu City Dujiangyan Chunsheng Chinese Medicine Drinks Coltd
Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港))
 
Broncus Holding Corporation (Hong Kong) (Broncus Holding Corporation (香港))
Shanghai Micurx Pharmaceutical Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo